Cell Line Development Market Size By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Source (Mammalian, Non-Mammalian {Insects, Amphibians}), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Published Date: Aug 2018  |  Report ID: GMI429  |  Authors: Sumant Ugalmugale

Report Format: PDF   |   Pages: 201   |   Base Year: 2017




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data Sources

1.4.1.  Secondary

1.4.1.1.   Paid Sources

1.4.1.2.    Unpaid Sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. Cell line development industry 360° synopsis, 2013 - 2024

2.1.1.  Business trends

2.1.2.  Product trends

2.1.3.  Source trends

2.1.4.  Cell line type trends

2.1.5.  Application trends

2.1.6.  Regional trends

Chapter 3.  Cell Line Development Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1.   Rise in production of vaccines globally

3.3.1.2.   Increasing number of cancer incidences especially in developing countries such as India and China

3.3.1.3.   Extended applications of biotechnology sector

3.3.1.4.   Patent expiration of blockbuster biologics leading to innovations in the field

3.3.1.5.   Escalating demand for monoclonal antibodies in U.S. and Europe

3.3.1.6.    Technological advancements in cell line development

3.3.2.  Industry pitfalls & challenges

3.3.2.1.   Ambiguous regulatory landscape

3.3.2.2.    Growing concerns related to stem cell research

3.4. Growth potential analysis

3.4.1.  By product

3.4.2.  By source

3.4.3.  By cell line type

3.4.4.  By application

3.5. Porter’s analysis

3.6. Regulatory landscape

3.6.1.  U.S.

3.6.2.  Europe

3.6.3.  China

3.7. Company landscape, 2017

3.7.1.  Strategy dashboard

3.8. PESTEL analysis

Chapter 4.  Cell Line Development Market, By Product

4.1. Key segment trends

4.2. Reagents and media

4.2.1.  Reagents and media market, by region, 2013 – 2024 (USD Million)

4.3. Equipment

4.3.1.  Equipment market, by region, 2013 - 2024, (USD Million)

4.3.2.  Incubators

4.3.2.1.  Incubators market, by region, 2013 - 2024, (USD Million)

4.3.3.  Centrifuges

4.3.3.1.  Centrifuges market, by region, 2013 - 2024, (USD Million)

4.3.4.  Bioreactors

4.3.4.1.  Bioreactors market, by region, 2013 - 2024, (USD Million)

4.3.5.  Storage equipment

4.3.5.1.  Storage equipment market, by region, 2013 - 2024, (USD Million)

4.3.6.  Microscopes

4.3.6.1.  Microscopes market, by region, 2013 - 2024, (USD Million)

4.4. Accessories and consumables

4.4.1.  Accessories and consumables market, by region, 2013 - 2024, (USD Million)

Chapter 5.  Cell Line Development Market, By Source

5.1. Key segment trends

5.2. Mammalian

5.2.1.  Mammalian cell line development market, by region, 2013 - 2024, (USD Million)

5.3. Non-mammalian

5.3.1.  Non-mammalian cell development market, by region 2013 - 2024, (USD Million)

5.3.2.  Insects

5.3.2.1.  Insect cell line development market, by region 2013 - 2024, (USD Million)

5.3.3.  Amphibians

5.3.3.1.  Amphibians cell line development market, by region 2013 - 2024, (USD Million)

Chapter 6.  Cell Line Development Market, By Cell Line Type

6.1. Key segment trends

6.2. Recombinant cell lines

6.2.1.  Recombinant cell line development market, by region, 2013 - 2024, (USD Million)

6.3. Hybridomas

6.3.1.  Hybridomas cell line development market, by region, 2013 - 2024, (USD Million)

6.4. Continuous cell lines

6.4.1.  Continuous cell line development market, by region, 2013 - 2024, (USD Million)

6.5. Primary cell lines

6.5.1.  Primary cell line development market, by region, 2013 - 2024, (USD Million)

Chapter 7.  Cell Line Development Market, By Application

7.1. Key segment trends

7.2. Bioproduction market

7.2.1.  Bioproduction market, by region, 2013 - 2024, (USD Million)

7.3. Drug discovery

7.3.1.  Drug discovery market, by region, 2013 - 2024, (USD Million)

7.4. Toxicity testing

7.4.1.  Toxicity testing market, by region, 2013 - 2024, (USD Million)

7.5. Tissue engineering

7.5.1.  Tissue engineering market, by region, 2013 - 2024, (USD Million)

7.6. Research

7.6.1.  Research market, by region, 2013 - 2024, (USD Million)

Chapter 8.  Cell Line Development Market, By Region

8.1. Key regional trends

8.2. North America

8.2.1.  North America cell line development market, by region, 2013 - 2024 (USD Million)

8.2.2.  North America cell line development market, by product, 2013 - 2024 (USD Million)

8.2.2.1.  North America cell line development market, by equipment, 2013 - 2024 (USD Million)

8.2.3.  North America cell line development market, by source, 2013 - 2024 (USD Million)

8.2.3.1.  North America cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.2.4.  North America cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.2.5.  North America cell line development market, by application, 2013 - 2024 (USD Million)

8.2.6.  U.S.

8.2.6.1.  U.S. cell line development market, by product, 2013 - 2024 (USD Million)

8.2.6.1.1. U.S. cell line development market, by equipment, 2013 - 2024 (USD Million)

8.2.6.2.  U.S. cell line development market, by source, 2013 - 2024 (USD Million)

8.2.6.2.1. U.S. cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.2.6.3.  U.S. cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.2.6.4.  U.S. cell line development market, by application, 2013 - 2024 (USD Million)

8.2.7.  Canada

8.2.7.1.  Canada cell line development market, by product, 2013 - 2024 (USD Million)

8.2.7.1.1. Canada cell line development market, by equipment, 2013 - 2024 (USD Million)

8.2.7.2.  Canada cell line development market, by source, 2013 - 2024 (USD Million)

8.2.7.2.1. Canada cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.2.7.3.  Canada cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.2.7.4.  Canada cell line development market, by application, 2013 - 2024 (USD Million)

8.3. Europe        

8.3.1.  Europe cell line development market, by country 2013 - 2024 (USD Million)

8.3.2.  Europe cell line development market, by product, 2013 - 2024 (USD Million)

8.3.2.1.  Europe cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.3.  Europe cell line development market, by source, 2013 - 2024 (USD Million)

8.3.3.1.  Europe cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.4.  Europe cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.5.  Europe cell line development market, by application, 2013 - 2024 (USD Million)

8.3.6.  Germany

8.3.6.1.  Germany cell line development market, by product, 2013 - 2024 (USD Million)

8.3.6.1.1. Germany cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.6.2.  Germany cell line development market, by source, 2013 - 2024 (USD Million)

8.3.6.2.1. Germany cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.6.3.  Germany cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.6.4.  Germany cell line development market, by application, 2013 - 2024 (USD Million)

8.3.7.  France

8.3.7.1.  France cell line development market, by product, 2013 - 2024 (USD Million)

8.3.7.1.1. France cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.7.2.  France cell line development market, by source, 2013 - 2024 (USD Million)

8.3.7.2.1. France cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.7.3.  France cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.7.4.  France cell line development market, by application, 2013 - 2024 (USD Million)

8.3.8.  UK

8.3.8.1.  UK cell line development market, by product, 2013 - 2024 (USD Million)

8.3.8.1.1. UK cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.8.2.  UK cell line development market, by source, 2013 - 2024 (USD Million)

8.3.8.2.1. UK cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.8.3.  UK cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.8.4.  UK cell line development market, by application, 2013 - 2024 (USD Million)

8.3.9.  Spain

8.3.9.1.  Spain cell line development market, by product, 2013 - 2024 (USD Million)

8.3.9.1.1. Spain cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.9.2.  Spain cell line development market, by source, 2013 - 2024 (USD Million)

8.3.9.2.1. Spain cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.9.3.  Spain cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.9.4.  Spain cell line development market, by application, 2013 - 2024 (USD Million)

8.3.10. Italy

8.3.10.1.  Italy cell line development market, by product, 2013 - 2024 (USD Million)

8.3.10.1.1.  Italy cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.10.2.  Italy cell line development market, by source, 2013 - 2024 (USD Million)

8.3.10.2.1.  Italy cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.10.3.  Italy cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.10.4.  Italy cell line development market, by application, 2013 - 2024 (USD Million)

8.3.11. Russia

8.3.11.1.  Russia cell line development market, by product, 2013 - 2024 (USD Million)

8.3.11.1.1.  Russia cell line development market, by equipment, 2013 - 2024 (USD Million)

8.3.11.2.  Russia cell line development market, by source, 2013 - 2024 (USD Million)

8.3.11.2.1.  Russia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.3.11.3.  Russia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.3.11.4.  Russia cell line development market, by application, 2013 - 2024 (USD Million)

8.4. Asia Pacific

8.4.1.  Asia Pacific cell line development market, by country, 2013 - 2024 (USD Million)

8.4.2.  Asia Pacific cell line development market, by product, 2013 - 2024 (USD Million)

8.4.2.1.  Asia Pacific cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.3.  Asia Pacific cell line development market, by source, 2013 - 2024 (USD Million)

8.4.3.1.  Asia Pacific cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.4.  Asia Pacific cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.5.  Asia Pacific cell line development market, by application, 2013 - 2024 (USD Million)

8.4.6.  Japan

8.4.6.1.  Japan cell line development market, by product, 2013 - 2024 (USD Million)

8.4.6.1.1. Japan cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.6.2.  Japan cell line development market, by source, 2013 - 2024 (USD Million)

8.4.6.2.1. Japan cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.6.3.  Japan cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.6.4.  Japan cell line development market, by application, 2013 - 2024 (USD Million)

8.4.7.  China

8.4.7.1.  China cell line development market, by product, 2013 - 2024 (USD Million)

8.4.7.1.1. China cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.7.2.  China cell line development market, by source, 2013 - 2024 (USD Million)

8.4.7.2.1. China cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.7.3.  China cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.7.4.  China cell line development market, by application, 2013 - 2024 (USD Million)

8.4.8.  India

8.4.8.1.  India cell line development market, by product, 2013 - 2024 (USD Million)

8.4.8.1.1. India cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.8.2.  India cell line development market, by source, 2013 - 2024 (USD Million)

8.4.8.2.1. India cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.8.3.  India cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.8.4.  India cell line development market, by application, 2013 - 2024 (USD Million)

8.4.9.  South Korea

8.4.9.1.  South Korea cell line development market, by product, 2013 - 2024 (USD Million)

8.4.9.1.1. South Korea cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.9.2.  South Korea cell line development market, by source, 2013 - 2024 (USD Million)

8.4.9.2.1. South Korea cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.9.3.  South Korea cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.9.4.  South Korea cell line development market, by application, 2013 - 2024 (USD Million)

8.4.10. Australia

8.4.10.1.  Australia cell line development market, by product, 2013 - 2024 (USD Million)

8.4.10.1.1.  Australia cell line development market, by equipment, 2013 - 2024 (USD Million)

8.4.10.2.  Australia cell line development market, by source, 2013 - 2024 (USD Million)

8.4.10.2.1.  Australia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.4.10.3.  Australia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.4.10.4.  Australia cell line development market, by application, 2013 - 2024 (USD Million)

8.5. Latin America

8.5.1.  Latin America cell line development market, by country 2013 – 2024 (USD Million)

8.5.2.  Latin America cell line development market, by product, 2013 - 2024 (USD Million)

8.5.2.1.  Latin America cell line development market, by equipment, 2013 - 2024 (USD Million)

8.5.3.  Latin America cell line development market, by source, 2013 - 2024 (USD Million)

8.5.3.1.  Latin America cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.5.4.  Latin America cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.5.5.  Latin America cell line development market, by application, 2013 - 2024 (USD Million)

8.5.6.  Mexico

8.5.6.1.  Mexico cell line development market, by product 2013 – 2024 (USD Million)

8.5.6.1.1. Mexico cell line development market, by equipment, 2013 – 2024 (USD Million)

8.5.6.2.  Mexico cell line development market, by source, 2013 - 2024 (USD Million)

8.5.6.2.1. Mexico cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.5.6.3.  Mexico cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.5.6.4.  Mexico cell line development market, by application, 2013 - 2024 (USD Million)

8.5.7.  Brazil

8.5.7.1.  Brazil cell line development market, by product 2013 – 2024 (USD Million)

8.5.7.1.1. Brazil cell line development market, by equipment, 2013 - 2024 (USD Million)

8.5.7.2.  Brazil cell line development market, by source, 2013 - 2024 (USD Million)

8.5.7.2.1. Brazil cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.5.7.3.  Brazil cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.5.7.4.  Brazil cell line development market, by application, 2013 - 2024 (USD Million)

8.6. MEA

8.6.1.  MEA cell line development market, by country 2013 – 2024 (USD Million)

8.6.2.  MEA cell line development market, by product, 2013 - 2024 (USD Million)

8.6.2.1.  MEA cell line development market, by equipment, 2013 - 2024 (USD Million)

8.6.3.  MEA cell line development market, by source, 2013 - 2024 (USD Million)

8.6.3.1.  MEA cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.6.4.  MEA cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.6.5.  MEA cell line development market, by application, 2013 - 2024 (USD Million)

8.6.6.  South Africa

8.6.6.1.  South Africa cell line development market, by product 2013 – 2024 (USD Million)

8.6.6.1.1.   South Africa cell line development market, by equipment, 2013 - 2024 (USD Million)

8.6.6.2.  South Africa cell line development market, by source, 2013 - 2024 (USD Million)

8.6.6.2.1.   South Africa cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.6.6.3.  South Africa cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.6.6.4.  South Africa cell line development market, by application, 2013 - 2024 (USD Million)

8.6.7.  Saudi Arabia

8.6.7.1.  Saudi Arabia cell line development market, by product 2013 – 2024 (USD Million)

8.6.7.1.1.   Saudi Arabia cell line development market, by equipment, 2013 - 2024 (USD Million)

8.6.7.2.  Saudi Arabia cell line development market, by source, 2013 - 2024 (USD Million)

8.6.7.2.1.   Saudi Arabia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

8.6.7.3.  Saudi Arabia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

8.6.7.4.  Saudi Arabia cell line development market, by application, 2013 - 2024 (USD Million)

Chapter 9.  Company Profiles

9.1. GE Healthcare

9.1.1.  Business Overview

9.1.2.  Financial Data

9.1.3.  Product Landscape

9.1.4.  Strategic Outlook

9.1.5.  SWOT Analysis

9.2. Thermo Fisher Scientific Inc.

9.2.1.  Business Overview

9.2.2.  Financial Data

9.2.3.  Product Landscape

9.2.4.  Strategic Outlook

9.2.5.  SWOT Analysis

9.3. Lonza Group AG

9.3.1.  Business Overview

9.3.2.  Financial Data

9.3.3.  Product Landscape

9.3.4.  Strategic Outlook

9.3.5.  SWOT Analysis

9.4. Sigma-Aldrich Corporation (Merck)

9.4.1.  Business Overview

9.4.2.  Financial Data

9.4.3.  Product Landscape

9.4.4.  Strategic Outlook

9.4.5.  SWOT Analysis

9.5. Cytovance Biologics

9.5.1.  Business Overview

9.5.2.  Financial Data

9.5.3.  Product Landscape

9.5.4.  Strategic Outlook

9.5.5.  SWOT Analysis

9.6. WuXi AppTec

9.6.1.  Business Overview

9.6.2.  Service Landscape

9.6.3.  Strategic Outlook

9.6.4.  SWOT Analysis

9.7. American Type Culture Collection

9.7.1.  Business Overview

9.7.2.  Product Landscape

9.7.3.  Strategic Outlook

9.7.4.  SWOT Analysis

9.8. Sartorius Stedim Biotech GmbH

9.8.1.  Business Overview

9.8.2.  Financial Data

9.8.3.  Product Landscape

9.8.4.  Strategic Outlook

9.8.5.  SWOT Analysis

9.9. Corning Inc.

9.9.1.  Business Overview

9.9.2.  Financial Data

9.9.3.  Product Landscape

9.9.4.  Strategic Outlook

9.9.5.  SWOT Analysis

9.10. Selexis SA

9.10.1. Business Overview

9.10.2. Product Landscape

9.10.3. Strategic Outlook

9.10.4. SWOT Analysis

9.11. Vista Biologicals Co.

9.11.1.   Business Overview

9.11.2.   Product Landscape

9.11.3.   Strategic Outlook

9.11.4.   SWOT Analysis

9.12. EuBiologics Co., Ltd.

9.12.1.   Business Overview

9.12.2.   Product Landscape

9.12.3.   Strategic Outlook

9.12.4.   SWOT Analysis

9.13. Paragon Bioservices

9.13.1.   Business Overview

9.13.2.   Service Landscape

9.13.3.   Strategic Outlook

9.13.4.   SWOT Analysis

9.14. Cobra Biologics

9.14.1.   Business Overview

9.14.2.   Service Landscape

9.14.3.   Strategic Outlook

9.14.4.   SWOT Analysis

9.15. Patheon

9.15.1.   Business Overview

9.15.2.   Financial Data

9.15.3.   Product Landscape

9.15.4.   Strategic Outlook

9.15.5.   SWOT Analysis

9.16. Samsung Biologics

9.16.1.   Business Overview

9.16.2.   Financial Data

9.16.3.   Product Landscape

9.16.4.   Strategic Outlook

9.16.5.   SWOT Analysis

9.17. NAEJA RGM Pharmaceuticals

9.17.1.   Business Overview

9.17.2.   Product Landscape

9.17.3.   SWOT Analysis

9.18. GVK BIO

9.18.1.   Business Overview

9.18.2.   Financial Data

9.18.3.   Product Landscape

9.18.4.   Strategic Outlook

9.18.5.   SWOT Analysis

9.19. Progenitor Cell Therapy (PCT)

9.19.1.   Business Overview

9.19.2.   Financial Data

9.19.3.   Product Landscape

9.19.4.   Strategic Outlook

9.19.5.   SWOT Analysis

9.20. Apath LLC

9.20.1.   Business Overview

9.20.2.   Product Landscape

9.20.3.   Strategic Outlook

9.20.4.   SWOT Analysis

9.21. Cell for Cure

9.21.1.   Business Overview

9.21.2.   Financial Data

9.21.3.   Product Landscape

9.21.4.   Strategic Outlook

9.21.5.   SWOT Analysis

9.22. Epistem Holdings Plc

9.22.1.   Business Overview

9.22.2.   Financial Data

9.22.3.   Product Landscape

9.22.4.   Strategic Outlook

9.22.5.   SWOT Analysis

9.23. Catalent Inc.

9.23.1.   Business Overview

9.23.2.   Financial Data

9.23.3.   Product Landscape

9.23.4.   Strategic Outlook

9.23.5.   SWOT Analysis

9.24. Bioceros

9.24.1.   Business Overview

9.24.2.   Product Landscape

9.24.3.   Strategic Outlook

9.24.4.   SWOT Analysis

9.25. Abzena PLC

9.25.1.   Business Overview

9.25.2.   Financial Data

9.25.3.   Product Landscape

9.25.4.   Strategic Outlook

9.25.5.   SWOT Analysis

9.26. Promocell

9.26.1.   Business Overview

9.26.2.   Product Landscape

9.26.3.   Strategic Outlook

9.26.4.   SWOT Analysis

9.27. Cyagen

9.27.1.   Business Overview

9.27.2.   Product Landscape

9.27.3.   SWOT Analysis

 

 

Data Tables

TABLE 1.    Cell line development industry 360° synopsis, 2013 – 2024

TABLE 2.    Global cell line development market, 2013 – 2024 (USD Mn)

TABLE 3.    Global cell line development market, by product, 2013 – 2017 (USD Mn)

TABLE 4.    Global cell line development market, by product, 2018 – 2024 (USD Mn)

TABLE 5.    Global cell line development market, by source, 2013 – 2017 (USD Mn)

TABLE 6.    Global cell line development market, by source, 2018 – 2024 (USD Mn)

TABLE 7.    Global cell line development market, by type of cell lines, 2013 – 2024 (USD Mn)

TABLE 8.    Global cell line development market, by type of cell lines, 2013 – 2024 (USD Mn)

TABLE 9.    Global cell line development market, by application, 2013 – 2024 (USD Mn)

TABLE 10.    Global cell line development market, by application, 2013 – 2024 (USD Mn)

TABLE 11.    Global cell line development market, by region, 2013 – 2024 (USD Million)

TABLE 12.    Industry impact forces

TABLE 13.    Reagents and media market by region, 2013 – 2024 (USD Million)

TABLE 14.    Equipment market, by region, 2013 - 2024, (USD Million)

TABLE 15.    Incubators market, by region, 2013 - 2024, (USD Million)

TABLE 16.    Centrifuges market, by region, 2013 - 2024, (USD Million)

TABLE 17.    Bioreactors market, by region, 2013 - 2024, (USD Million)

TABLE 18.    Storage equipment market, by region, 2013 - 2024, (USD Million)

TABLE 19.    Microscopes market, by region, 2013 - 2024, (USD Million)

TABLE 20.    Accessories and consumables market, by region, 2013 - 2024, (USD Million)

TABLE 21.    Mammalian cell line development market, by region, 2013 - 2024, (USD Million)

TABLE 22.    Non-mammalian cell development market, by region 2013 - 2024, (USD Million)

TABLE 23.    Insect cell line development market, by region 2013 - 2024, (USD Million)

TABLE 24.    Amphibians cell line development market, by region 2013 - 2024, (USD Million)

TABLE 25.    Recombinant cell line development market, by region, 2013 - 2024, (USD Million)

TABLE 26.    Hybridomas cell line development market, by region, 2013 - 2024, (USD Million)

TABLE 27.    Continuous cell line development market, by region, 2013 - 2024, (USD Million)

TABLE 28.    Primary cell line development market, by region, 2013 - 2024, (USD Million)

TABLE 29.    Bioproduction market, by region, 2013 - 2024, (USD Million)

TABLE 30.    Drug discovery market, by region, 2013 - 2024, (USD Million)

TABLE 31.    Toxicity testing market, by region, 2013 - 2024, (USD Million)

TABLE 32.    Tissue engineering market, by region, 2013 - 2024, (USD Million)

TABLE 33.    Research market, by region, 2013 - 2024, (USD Million)

TABLE 34.    North America cell line development market, by country 2013 - 2024 (USD Million)

TABLE 35.    North America cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 36.    North America cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 37.    North America cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 38.    North America cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 39.    North America cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 40.    North America cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 41.    U.S. cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 42.    U.S. cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 43.    U.S. cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 44.    U.S. cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 45.    U.S. cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 46.    U.S. cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 47.    Canada cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 48.    Canada cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 49.    Canada cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 50.    Canada cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 51.    Canada cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 52.    Canada cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 53.    Europe cell line development market, by country 2013 - 2024 (USD Million)

TABLE 54.    Europe cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 55.    Europe cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 56.    Europe cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 57.    Europe cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 58.    Europe cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 59.    Europe cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 60.    Germany cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 61.    Germany cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 62.    Germany cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 63.    Germany cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 64.    Germany cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 65.    Germany cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 66.    France cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 67.    France cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 68.    France cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 69.    France cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 70.    France cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 71.    France cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 72.    UK cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 73.    UK cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 74.    UK cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 75.    UK cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 76.    UK cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 77.    UK cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 78.    Spain cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 79.    Spain cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 80.    Spain cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 81.    Spain cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 82.    Spain cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 83.    Spain cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 84.    Italy cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 85.    Italy cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 86.    Italy cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 87.    Italy cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 88.    Italy cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 89.    Italy cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 90.    Russia cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 91.    Russia cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 92.    Russia cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 93.    Russia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 94.    Russia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 95.    Russia cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 96.    Asia Pacific cell line development market, by country, 2013 - 2024 (USD Million)

TABLE 97.    Asia Pacific cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 98.    Asia Pacific cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 99.    Asia Pacific cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 100.    Asia Pacific cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 101.    Asia Pacific cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 102.    Asia Pacific cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 103.    Japan cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 104.    Japan cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 105.    Japan cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 106.    Japan cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 107.    Japan cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 108.    Japan cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 109.    China cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 110.    China cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 111.    China cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 112.    China cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 113.    China cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 114.    China cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 115.    India cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 116.    India cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 117.    India cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 118.    India cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 119.    India cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 120.    India cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 121.    South Korea cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 122.    South Korea cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 123.    South Korea cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 124.    South Korea cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 125.    South Korea cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 126.    South Korea cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 127.    Australia cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 128.    Australia cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 129.    Australia cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 130.    Australia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 131.    Australia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 132.    Australia cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 133.    Latin America cell line development market, by country 2013 – 2024 (USD Million)

TABLE 134.    Latin America cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 135.    Latin America cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 136.    Latin America cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 137.    Latin America cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 138.    Latin America cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 139.    Latin America cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 140.    Mexico cell line development market, by product 2013 – 2024 (USD Million)

TABLE 141.    Mexico cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 142.    Mexico cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 143.    Mexico cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 144.    Mexico cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 145.    Mexico cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 146.    Brazil cell line development market, by product 2013 – 2024 (USD Million)

TABLE 147.    Brazil cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 148.    Brazil cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 149.    Brazil cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 150.    Brazil cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 151.    Brazil cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 152.    MEA cell line development market, by country 2013 – 2024 (USD Million)

TABLE 153.    MEA cell line development market, by product, 2013 - 2024 (USD Million)

TABLE 154.    MEA cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 155.    MEA cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 156.    MEA cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 157.    MEA cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 158.    MEA cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 159.    South Africa cell line development market, by product 2013 – 2024 (USD Million)

TABLE 160.    South Africa cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 161.    South Africa cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 162.    South Africa cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 163.    South Africa cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 164.    South Africa cell line development market, by application, 2013 - 2024 (USD Million)

TABLE 165.    Saudi Arabia cell line development market, by product 2013 – 2024 (USD Million)

TABLE 166.    Saudi Arabia cell line development market, by equipment, 2013 - 2024 (USD Million)

TABLE 167.    Saudi Arabia cell line development market, by source, 2013 - 2024 (USD Million)

TABLE 168.    Saudi Arabia cell line development market, by non-mammalian source 2013 - 2024 (USD Million)

TABLE 169.    Saudi Arabia cell line development market, by type of cell lines, 2013 - 2024 (USD Million)

TABLE 170.    Saudi Arabia cell line development market, by application, 2013 - 2024 (USD Million)

 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global cell line development market, 2013 – 2024 (USD Million)

FIG. 3    Cancer prevalence across regions, 2012

FIG. 4    Cancer incidence in the U.S., 2005-2015

FIG. 5    Growth potential analysis, by product

FIG. 6    Growth potential analysis, by source

FIG. 7    Growth potential analysis, by cell line type

FIG. 8    Growth potential analysis, by application

FIG. 9    Porter’s analysis

FIG. 10    Company market share analysis, 2016

FIG. 11    Strategy dashboard, 2017

FIG. 12    PESTEL analysis

FIG. 13    Rates of new cancer cases in the U.S. (State-wise data per 100,000 people in 2013)

 

Buy NowImmediate delivery available

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X